HEADER TRANSFERASE 08-FEB-08 2VO3 TITLE STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1- TITLE 2 (7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTEIN KINASE A, PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 10 CHAIN: I; COMPND 11 FRAGMENT: RESIDUES 6-25; COMPND 12 SYNONYM: PKI, PKI-ALPHA, CAMP- DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 13 MUSCLE/BRAIN ISOFORM; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS TRANSFERASE, LIPOPROTEIN, ATP-BINDING, PHOSPHOPROTEIN, KEYWDS 2 SERINE/THREONINE-PROTEIN KINASE, NUCLEOTIDE-BINDING, PROTEIN KINASE KEYWDS 3 INHIBITOR, CAMP, KINASE, NUCLEUS, MYRISTATE, CYTOPLASM EXPDTA X-RAY DIFFRACTION AUTHOR J.J.CALDWELL,T.G.DAVIES,A.DONALD,T.MCHARDY,M.G.ROWLANDS,G.W.AHERNE, AUTHOR 2 L.K.HUNTER,K.TAYLOR,R.RUDDLE,F.I.RAYNAUD,M.VERDONK,P.WORKMAN, AUTHOR 3 M.D.GARRETT,I.COLLINS REVDAT 4 23-OCT-24 2VO3 1 LINK REVDAT 3 24-FEB-09 2VO3 1 VERSN REVDAT 2 29-APR-08 2VO3 1 JRNL REMARK REVDAT 1 08-APR-08 2VO3 0 JRNL AUTH J.J.CALDWELL,T.G.DAVIES,A.DONALD,T.MCHARDY,M.G.ROWLANDS, JRNL AUTH 2 G.W.AHERNE,L.K.HUNTER,K.TAYLOR,R.RUDDLE,F.I.RAYNAUD, JRNL AUTH 3 M.VERDONK,P.WORKMAN,M.D.GARRETT,I.COLLINS JRNL TITL IDENTIFICATION OF JRNL TITL 2 4-(4-AMINOPIPERIDIN-1-YL)-7H-PYRROLO[2,3-D]PYRIMIDINES AS JRNL TITL 3 SELECTIVE INHIBITORS OF PROTEIN KINASE B THROUGH FRAGMENT JRNL TITL 4 ELABORATION. JRNL REF J.MED.CHEM. V. 51 2147 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18345609 JRNL DOI 10.1021/JM701437D REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019I REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 28726 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1538 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.98 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.03 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1817 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE SET COUNT : 114 REMARK 3 BIN FREE R VALUE : 0.3210 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2945 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 341 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.76000 REMARK 3 B22 (A**2) : 0.42000 REMARK 3 B33 (A**2) : -1.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.175 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.170 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.116 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.060 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3048 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2135 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4116 ; 1.299 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5169 ; 0.887 ; 2.990 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 355 ; 5.644 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 151 ;37.806 ;23.841 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 541 ;14.466 ;15.055 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;22.249 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 423 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3333 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 661 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 625 ; 0.204 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2236 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1475 ; 0.184 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1519 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 69 ; 0.108 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 3 ; 0.065 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 22 ; 0.278 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.122 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1777 ; 0.077 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2866 ; 0.101 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1271 ; 0.098 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1250 ; 0.121 ; 7.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. ALTHOUGH THERE IS EVIDENCE FOR A SECOND INHIBITOR REMARK 3 BINDING SITE NEAR LYS 292, ONLY THE PYRROLO- PYRIMIDINE MOIETY REMARK 3 COULD BE FITTED WITH CONFIDENCE, AND SO THIS SITE HAS NOT BEEN REMARK 3 BUILT IN THE FINAL MODEL. REMARK 4 REMARK 4 2VO3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-FEB-08. REMARK 100 THE DEPOSITION ID IS D_1290035286. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28726 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 33.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.23000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.56200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.96650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.23850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.96650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.56200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.23850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, VAL 105 TO THR REMARK 400 ENGINEERED RESIDUE IN CHAIN A, VAL 124 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 174 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 182 TO LYS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 GLN A 12 REMARK 465 GLU A 13 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 99 115.80 -163.01 REMARK 500 ASP A 166 54.00 -151.90 REMARK 500 THR A 183 -162.63 -103.33 REMARK 500 SER A 252 -38.35 -39.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2010 DISTANCE = 6.73 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE M04 A1352 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XH6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 2VNW RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL) REMARK 900 PIPERIDIN-4-YL) METHANAMINE REMARK 900 RELATED ID: 1YDR RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT REMARK 900 IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR1-(5- REMARK 900 ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE REMARK 900 RELATED ID: 1SVE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE REMARK 900 DERIVATIVE 1 REMARK 900 RELATED ID: 2UVZ RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-(9H-PURIN- REMARK 900 6-YL)-PHENYL )-METHYLAMINE REMARK 900 RELATED ID: 1XH4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 2UVX RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE REMARK 900 RELATED ID: 1Q8U RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE INCOMPLEX REMARK 900 WITH RHO-KINASE INHIBITOR H-1152P REMARK 900 RELATED ID: 2F7E RELATED DB: PDB REMARK 900 PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL )-1-(5-ISOQUINOLIN-6-YL- REMARK 900 PYRIDIN-3- YLOXYMETHYL-ETYLAMINE REMARK 900 RELATED ID: 2VO6 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1- REMARK 900 (7H-PYRROLO(2,3-D )PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE REMARK 900 RELATED ID: 1KMU RELATED DB: PDB REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT- REGULATORY SUBUNITDIMERIC REMARK 900 COMPLEX OF THE CAMP -DEPENDENT PROTEIN KINASE REMARK 900 RELATED ID: 1CMK RELATED DB: PDB REMARK 900 RELATED ID: 2UW7 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4- REMARK 900 (4-(1H-PYRAZOL-4 -YL)-PHENYL)-PIPERIDINE REMARK 900 RELATED ID: 2JDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A-443654 REMARK 900 RELATED ID: 1Q62 RELATED DB: PDB REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB REMARK 900 RELATED ID: 2UW8 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO-PHENYL)-2- REMARK 900 PHENYL-ETHYLAMINE REMARK 900 RELATED ID: 2GNF RELATED DB: PDB REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632 REMARK 900 RELATED ID: 2UZU RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS REMARK 900 RELATED ID: 2UW3 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4-PHENYL-1H- REMARK 900 PYRAZOLE REMARK 900 RELATED ID: 2C1A RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH REMARK 900 ISOQUINOLINE-5-SULFONIC ACID ( 2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO) REMARK 900 ETHYL) AMIDE REMARK 900 RELATED ID: 1SMH RELATED DB: PDB REMARK 900 PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N-TERMINAL REMARK 900 HELIX REMARK 900 RELATED ID: 2UW4 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL-1H- REMARK 900 PYRAZOL-4-YL)-PHENYL )-ETHYLAMINE REMARK 900 RELATED ID: 1VEB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE REMARK 900 DERIVATIVE 5 REMARK 900 RELATED ID: 2C1B RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH (4R,2S)-5' REMARK 900 -(4-(4- CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL) ISOQUINOLINE REMARK 900 RELATED ID: 2GNL RELATED DB: PDB REMARK 900 PKA THREEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR H-1152P REMARK 900 RELATED ID: 1JLU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 900 PROTEIN KINASE COMPLEXED WITH A PHOSPHORYLATEDSUBSTRATE PEPTIDE AND REMARK 900 DETERGENT REMARK 900 RELATED ID: 1XH7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 2UZV RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS REMARK 900 RELATED ID: 1Q24 RELATED DB: PDB REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP REMARK 900 RELATED ID: 2VNY RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL) REMARK 900 PIPERIDIN-4-YL)AMINE REMARK 900 RELATED ID: 2UW6 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4-CHLORO-PHENYL)- REMARK 900 2-(4-1H- PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE REMARK 900 RELATED ID: 1SVG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE REMARK 900 DERIVATIVE 4 REMARK 900 RELATED ID: 1KMW RELATED DB: PDB REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT- REGULATORY SUBUNITDIMERIC REMARK 900 COMPLEX OF THE C- AMP-DEPENDENT PROTEIN KINASE REMARK 900 RELATED ID: 1XHA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 2GNJ RELATED DB: PDB REMARK 900 PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632 REMARK 900 RELATED ID: 2UVY RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H-PURIN-6- REMARK 900 YL)-BENZYL)-AMINE REMARK 900 RELATED ID: 2VO0 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1- REMARK 900 (7H-PYRROLO(2, 3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL) METHYLAMINE REMARK 900 RELATED ID: 2GNH RELATED DB: PDB REMARK 900 PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P REMARK 900 RELATED ID: 2GFC RELATED DB: PDB REMARK 900 CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITHPKI-5-24 REMARK 900 RELATED ID: 1SZM RELATED DB: PDB REMARK 900 DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEINKINASE A (PKA) REMARK 900 RELATED ID: 1Q61 RELATED DB: PDB REMARK 900 PKA TRIPLE MUTANT MODEL OF PKB REMARK 900 RELATED ID: 2GNG RELATED DB: PDB REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE REMARK 900 RELATED ID: 1YDT RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT REMARK 900 IN COMPLEX WITH H89 PROTEIN KINASE INHIBITORN-[2-(4- REMARK 900 BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE REMARK 900 RELATED ID: 2UZT RELATED DB: PDB REMARK 900 PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS REMARK 900 RELATED ID: 1Q8W RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE INCOMPLEX REMARK 900 WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077) REMARK 900 RELATED ID: 1SVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE REMARK 900 DERIVATIVE 8 REMARK 900 RELATED ID: 2UZW RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS REMARK 900 RELATED ID: 2UW0 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4-(4-CHLORO- REMARK 900 PHENYL)-PIPERIDIN-4- YL)-PHENYL)-9H-PURINE REMARK 900 RELATED ID: 2JDV RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654 REMARK 900 RELATED ID: 2UW5 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4-CHLORO-PHENYL)- REMARK 900 2-(4-1H- PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE REMARK 900 RELATED ID: 2GNI RELATED DB: PDB REMARK 900 PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITORFASUDIL REMARK 900 (HA1077) REMARK 900 RELATED ID: 1XH5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1YDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT REMARK 900 IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR[N-(2-METHYLAMINO) ETHYL] REMARK 900 -5-ISOQUINOLINESULFONAMIDE REMARK 900 RELATED ID: 1STC RELATED DB: PDB REMARK 900 CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT INCOMPLEX REMARK 900 WITH STAUROSPORINE REMARK 900 RELATED ID: 2JDT RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5-SULFONIC REMARK 900 ACID (2-(2-(4- CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE REMARK 900 RELATED ID: 1Q8T RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE(PKA) IN REMARK 900 COMPLEX WITH RHO- KINASE INHIBITOR Y-27632 REMARK 900 RELATED ID: 1XH8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 999 REMARK 999 SEQUENCE REMARK 999 4 RESIDUES OF THE WILD-TYPE PKA SEQUENCE HAVE BEEN MUTATED REMARK 999 TO THE CORRESPONDING RESIDUES IN PKB DBREF 2VO3 A 0 350 UNP P00517 KAPCA_BOVIN 1 351 DBREF 2VO3 I 5 24 UNP P61925 IPKA_HUMAN 6 25 SEQADV 2VO3 THR A 104 UNP P00517 VAL 105 ENGINEERED MUTATION SEQADV 2VO3 ALA A 123 UNP P00517 VAL 124 ENGINEERED MUTATION SEQADV 2VO3 MET A 173 UNP P00517 LEU 174 ENGINEERED MUTATION SEQADV 2VO3 LYS A 181 UNP P00517 GLN 182 ENGINEERED MUTATION SEQRES 1 A 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN SEQRES 2 A 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 351 PHE LEU LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA SEQRES 4 A 351 HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR SEQRES 5 A 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU SEQRES 6 A 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 351 GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 351 THR LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 351 TYR MET VAL MET GLU TYR ALA PRO GLY GLY GLU MET PHE SEQRES 11 A 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU PRO HIS SEQRES 12 A 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 351 PRO GLU ASN LEU MET ILE ASP GLN GLN GLY TYR ILE LYS SEQRES 15 A 351 VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 A 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 A 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 A 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 A 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 A 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 A 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 A 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 A 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 A 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 A 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 A 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 2VO3 SEP A 139 SER PHOSPHOSERINE MODRES 2VO3 TPO A 197 THR PHOSPHOTHREONINE MODRES 2VO3 SEP A 338 SER PHOSPHOSERINE HET SEP A 139 10 HET TPO A 197 11 HET SEP A 338 10 HET CL A1351 1 HET M04 A1352 25 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM CL CHLORIDE ION HETNAM M04 1-[4-(4-CHLOROBENZYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4- HETNAM 2 M04 YL)PIPERIDIN-4-YL]METHANAMINE HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 CL CL 1- FORMUL 4 M04 C19 H22 CL N5 FORMUL 5 HOH *341(H2 O) HELIX 1 1 SER A 14 ASN A 32 1 19 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 GLN A 96 1 13 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 GLU A 140 LEU A 160 1 21 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 ASP A 184 ALA A 188 5 5 HELIX 9 9 THR A 201 LEU A 205 5 5 HELIX 10 10 ALA A 206 LEU A 211 1 6 HELIX 11 11 LYS A 217 GLY A 234 1 18 HELIX 12 12 GLN A 242 GLY A 253 1 12 HELIX 13 13 SER A 262 LEU A 273 1 12 HELIX 14 14 VAL A 288 ASN A 293 1 6 HELIX 15 15 HIS A 294 ALA A 298 5 5 HELIX 16 16 ASP A 301 GLN A 307 1 7 HELIX 17 17 THR I 5 SER I 13 1 9 SHEET 1 AA 5 PHE A 43 GLY A 52 0 SHEET 2 AA 5 GLY A 55 HIS A 62 -1 O GLY A 55 N GLY A 52 SHEET 3 AA 5 HIS A 68 ASP A 75 -1 O TYR A 69 N VAL A 60 SHEET 4 AA 5 ASN A 115 GLU A 121 -1 O LEU A 116 N LEU A 74 SHEET 5 AA 5 LEU A 106 LYS A 111 -1 N GLU A 107 O VAL A 119 SHEET 1 AB 2 LEU A 162 ILE A 163 0 SHEET 2 AB 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AC 2 LEU A 172 ILE A 174 0 SHEET 2 AC 2 ILE A 180 VAL A 182 -1 O LYS A 181 N MET A 173 SHEET 1 AD 2 CYS A 199 GLY A 200 0 SHEET 2 AD 2 ILE I 22 HIS I 23 -1 O ILE I 22 N GLY A 200 LINK C PHE A 138 N SEP A 139 1555 1555 1.34 LINK C SEP A 139 N GLU A 140 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 SITE 1 AC1 4 LYS A 72 ASP A 184 M04 A1352 HOH A2109 SITE 1 AC2 17 GLY A 50 THR A 51 GLY A 52 GLY A 55 SITE 2 AC2 17 VAL A 57 ALA A 70 LEU A 74 THR A 104 SITE 3 AC2 17 GLU A 121 ALA A 123 GLU A 127 GLU A 170 SITE 4 AC2 17 ASN A 171 MET A 173 ASP A 184 CL A1351 SITE 5 AC2 17 HOH A2181 CRYST1 73.124 74.477 79.933 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013675 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013427 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012510 0.00000